Meet The Team Products Contact Home

AWAKEN YOUR METABOLISM

Part 1 References

  1. Ravaglia G, et al. Determinants of functional status in healthy Italian nonagenarians and centenarians: a comprehensive functional assessment by the instruments of geriatric practice. J Am Geriatr Soc. 1997 Oct;45(10):1196-202.
  2. King BJ. Fat Wars: 45 Days To Transform Your Body. CDG Books. Toronto, Ont. 2002. (pg.11)
  3. Brochu M, etal. Coronary risk profiles in men with coronary artery disease: effects of body composition, fat distribution, age and fitness. Coron Artery Dis. 2000 Mar;11 (2):137-44.
  4. King, BJ. Fat Wars: 45 Days to Transform Your Body. CDG Books. Toronto, Ont. 2002, pg. 10
  5. Marieb, E.N. Essentials of Human Anatomy and Physiology. 6th ed. San Francisco: Addison Wesley Longman Inc., 2000.
  6. Thompson, P.D., Cullinane, E.M., Eshleman, R., Kantor, M.A., & Herbert, P.N. (1984). The effects of high-carbohydrate and high-fat diets on the serum lipid and lipoprotein concentrations of endurance athletes. Metabolism 33, 1003-1010.
  7. Taskinen, M.R., and E. Nikkila. “Lipoprotein Lipase of Adipose Tissue and Skeletal Muscle in Human Obesity” Metabolism 30 (1981): 810-817.
  8. Bertics, PJ. Additional Sample Questions, Work Sheets and Study Guide. Biomolecular Chemistry 704, 2004.
  9. Holm C, et al. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. .Annu Rev Nutr. 2000;20:365-93.
  10. Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans. 2003 Dec;31(Pt 6):1120-4.
  11. Ray H, et al. The presence of a catalytically inactive form of hormone-sensitive lipase is associated with decreased lipolysis in abdominal subcutaneous adipose tissue of obese subjects. Diabetes. 2003 Jun;52(6):1417-22.
  12. Qader SS, et al. Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release. Regul Pept. 2005 May 15;128(1):51-6.
  13. Vorona, RD, et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med. 2005 Jan 10; 165(1):25-30.
  14. Shahrad, Taheri, et al. Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index. 2004 Dec. Volume 1, Issue 3
  15. Spiegel, K, et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004 Dec 7; 141(11):846-50.
  16. Lucidi P, et al. Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults. Clin Endocrinol (Oxf). 2000 Feb;52(2):173-9.
  17. Klein, D.C.; Moore, R.Y.; & Reppert, S.M. Suprachiasmatic Nucleus: The Mind’s Clock. New York: Oxford University Press, 1991.
  18. Wajnrajch MP. Physiological and pathological growth hormone secretion. J Pediatr Endocrinol Metab. 2005 Apr;18(4):325-38.
  19. Isidro ML, et al. Neuroendocrine disturbances in obesity. Rev Med Univ Navarra. 2004 Apr-Jun;48(2):24-9.
  20. Craig BW, Brown R, Everhart J. Effects of progressive resistance training on growth hormone and testosterone levels in young and elderly subjects. Mech Ageing Dev. 1989 Aug;49(2):159-69.
  21. Pelletier, C., Despres, J.P., & Tremblay, A. (2002). Plasma organochlorine concentrations in endurance athletes and obese individuals. Medicine an science in Sports and Exercise, 34, 1971-1975.
  22. Fukuwatari T, Suzuki Y, Sugimoto E, Shibata K. Elucidation of the toxic mechanism of the plasticizers, phthalic acid esters, putative endocrine disrupters: effects of dietary di(2-ethylhexyl)phthalate on the metabolism of tryptophan to niacin in rats. Biosci Biotechnol Biochem. 2002 Apr;66(4):705-10.
  23. Imbeault, P., Tremblay, A., Simoneau, J.A., & Joanisse, D.R. Weight loss-induced rise in plasma pollutant is associated with reduced skeletal muscle oxidative capacity. American Journal of Physiology, 2000, E282, 574-579
  24. Harvey PW, Darbre P. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? J Appl Toxicol. 2004 May-Jun;24(3):167-76.
  25. Wilkinson HA, Dahlund J, Liu H, et al. Identification and characterization of a functionally distinct form of human estrogen receptor beta. Endocrinology. 2002 Apr;143(4):1558-61.
  26. Horard B, Vanacker JM. Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J Mol Endocrinol. 2003 Dec;31(3):349-57.
  27. Greschik H, Wurtz JM, Sanglier S, et al. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol Cell. 2002 Feb;9(2):303-13.
  28. Zeligs, M.A. “Plant-Powered Weight Loss: Phytonutrition for a Fat-Burning Metabolism.” (2001).
  29. Fishman J, Schneider J, Hershcope RJ, Bradlow HL. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem. 1984 Apr;20(4B):1077-81.
  30. Matsuda T, Abe H, Suda K. Relation between benign prostatic hyperplasia and obesity and estrogen. Rinsho Byori. 2004 Apr;52(4):291-4.
  31. Farnsworth WE. Estrogen in the etiopathogenesis of BPH. Prostate, 1999, 41:263-74.
  32. King, BJ. Fat Wars Action Planner. Wiley & Sons. Toronto, Ont. 2003, pg. 51.
  33. Waters DL, et al. Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging. J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):648-52.
  34. Laaksonen DE, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004 May;27(5):1036-41.
  35. Finn, C. The forgotten symptoms of low testosterone levels. The facts About Fitness.
  36. Vermeulen, A., et al. “Testosterone, Body Composition and Aging.” J Endocrinol Invest 22, no. 5 (1999): 110-116.
  37. Thakur, MK. Sex Steroid Signaling During Aging. Proceedings of the Indian National Science Academy. B69, n.2 pp 179-190 1, pr. 2003.
  38. Shippen, E., and W. Fryer. The Testosterone Syndrome: The Critical Factor for Energy, Health and Sexuality. New York: M. Evans and Company,2001.
  39. Remer T. Dietary protein and fiber intake and sex hormone-binding globulin. J Clin Endocrinol Metab. 2001 Feb;86(2):950.
  40. Mooradian AD, et al. Effect of free fatty acids on the bioavailability of plasma testosterone and dihydrotestosterone. Steroid Biochem. 1988 Mar;29(3):369-70.
  41. Longcope C, et al. Diet and sex hormone-binding globulin. J Clin Endocrinol Metab. 2000 Jan;85(1):293-6.
  42. Nindl BC, et al. Testosterone responses after resistance exercise in women: influence of regional fat distribution. Int J Sport Nutr Exerc Metab. 2001 Dec;11(4):451-65.
  43. Kreuz, LE. Suppression of plasma testosterone levels and psychological stress. A longitudinal study of young men in Officer Candidate School. Arch Gen Psychiatry. 1972 May;26(5):479-82.
  44. Ahmed A, Tollefsbol T. Telomeres and telomerase: basic science implications for aging. J Am Geriatr Soc. 2001 Aug;49(8):1105-9.
  45. Campisi J, Kim SH, Lim CS, Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol. 2001 Nov;36(10):1619-37.
  46. Gardner JP, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 2005 May 3;111(17):2171-7. Epub 2005 Apr 25.
  47. van Pelt, R.E., et al. Age-related decline in RMR in physically active men: relation to exercise volume and energy intake. American Journal of Physiology, E281, (2001) 633-639.
  48. Eaton, S.B, et al. “An Evolutionary Perspective Enhances Understanding of Human Nutritional Requirements.” Journal of Nutrition 126 (1996): 1732-1740.
  49. Braly J and Hoggan R. Dangerous Grains. Penguin Putnam Inc. New york, NY. 2002, pg. 20.
  50. Alvin and Heidi Toffler. Creating A New Civilization: The Politics of the Third Wave. Atlanta,Ga.:Turner Publishing Inc., 1995.
  51. Cordain, L. The Paleo Diet. John Wiley & Sons, Inc. Hoboken, New Jersey. 2002
  52. Eaton, S.B, et al. “An Evolutionary Perspective Enhances Understanding of Human Nutritional Requirements.” Journal of Nutrition 126 (1996): 1732-1740.
  53. King BJ. Fat Wars: 45 Days To Transform Your Body. CDG Books. Toronto, Ont. 2002. (pg.17)
  54. Eades, M.R., and M.D. Eades. Protein Power. New York: Bantam, 1999.
  55. Serdula, Mary. Prevalence of Attempting Weight Loss and Strategies for Controlling Weight. Journal of the American Medical Association. Vol. 282, No. 14.
  56. Serdula, Mary K., et.al. Prevalence of Attempting Weight Loss and Strategies for Controlling Weight. Journal of the American Medical Association. October 13, 1999. Vol. 282, No. 14.
  57. Koplan, Jeffrey P.and Dietz, William H. Caloric Imbalance and Public Health Policy. Journal of the American Medical Association. October 27, 1999. Vo. 282, No. 16.
  58. Forbes, G.B. (2000). Body fat content influences the body composition response to nutrition and exercise. Annals of the New York Academy of Sciences, 904, 359-365.
  59. Bryner, R.W., Ullrich, I.H., Sauers, J., Donley, D., Hornsby, G., Kolar, M., & Yeater, R. (1999). Effects of resistance vs. aerobic training combined with an 800 calorie liquid diet on lean body mass and resting metabolic rate. J. Amer. College Nut., 18, 115-121.
  60. Biolo, G., et al. “An Abundant Supply of Amino-Acids Enhances the Metabolic Effect of Exercise on Muscle Protein.” Amer J Phys 273 (1997): E122-E129.
  61. Sanchez A, Hubbard RW. Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosis. Med Hypotheses. 1991 Sep;36(1):27-32.
  62. Balage M, et al. Effect of dietary protein level on the first steps of glucagon action in rat liver plasma membranes. J Nutr. 1986 Sep;116(9):1810-9.
  63. Robinson, S.M., et al. “Protein Turnover and Thermogenesis in Response to High-Protein and High-Carbohydrate Feeding in Men.” Am J Clin Nutr 52, no. 1 (1990): 72-80.
  64. Eades, M.R., and M.D. Eades. Protein Power. New York: Bantam Books, 1999.
  65. Barenys, M., et al. “Effect of Exercise and Protein Intake on Energy Expenditure in Adolescents.” Rev Esp Fisiol 49, no. 4 (1993): 209-217.
  66. Biolo, G., et al. “An Abundant Supply of Amino-Acids Enhances the Metabolic Effect of Exercise on Muscle Protein.” Amer J Phys 273 (1997): E122-E129.
  67. Phillips SM, Hartman JW, Wilkinson SB.J Dietary protein to support anabolism with resistance exercise in young men. Am Coll Nutr. 2005 Apr;24(2):134S-139S.
  68. Baba, N.H., et al. “High Protein vs. High Carbohydrate Hypoenergetic Diet for the Treatment of Obese Hyperinsulinemic Subjects.” Int J Obes Relat Metab Disord 23, no. 11 (1999): 1202-1206.
  69. King, B.J., and M.A. Schmidt. Bio-Age: Ten Steps to a Younger You. Toronto: Macmillan, 2001, pg. 87.
  70. Hudgins, L.C. , et al. “Human Fatty Acid Synthesis Is Stimulated by a Eucaloric Low-Fat, High-Carbohydrate Diet.” J Clin Invest 97 (1996):2081–2091.
  71. Rouse, L.R., et al. “Effects of Isoenergetic, Low-Fat Diets on Energy Metabolism in Lean and Obese Women.” Am J Clin Nutr 60 (1994):470–475.
  72. Schlundt, D. “Randomized Evaluation of a Low-Fat Diet for Weight Reduction.” Int J Obesity 17 (1993):623–629.
  73. Blackburn G. Fats: the good, the bad, the trans. Health News. 1999 Jul 25;5(9):1-2.
  74. Trichopoulou A, et al. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ. 2005 Apr 30;330(7498):991. Epub 2005 Apr 8.
  75. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999 Sep;70(3 Suppl):560S-569S.
  76. “America: Drowning in Sugar” Experts Call for Food Labels to Disclose Added Sugars. Center For Science in The Public Interest issue date (1999).
  77. Cordain, L. Life Service Supplement News, July 26, 1999.
  78. McDowdl, M.A., et al. Energy and Macronutrient Intakes of Persons Ages 2 Months and Over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91.
  79. Liljeberg HG, Akerberg AK, Bjorck IM. Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am J Clin Nutr. 1999 Apr;69(4):647-55.
  80. Colombani PC. Glycemic index and load-dynamic dietary guidelines in the context of diseases. Physiol Behav. 2004 Dec 30;83(4):603-10.
  81. Davis MS, Miller CK, Mitchell DC. More favorable dietary patterns are associated with lower glycemic load in older adults. J Am Diet Assoc. 2004 Dec;104(12):1828-35.
  82. Epstein, S. The Politics of Cancer. East Ridge Press Fremont Center, New York , 1998
  83. King, BJ. Fat Wars Action Planner. Wiley & Sons. Toronto, Ont. 2003, pg. 121.
  84. Batmanghelidj, F. Your Body's Many Cries for Water. Global Health Solutions. Falls Church, VA, 1997
  85. Cherniske, S. The Metabolic Plan : Stay Younger Longer. Ballantine Books. New York. NY. Pg. 222, 2004
  86. Dolny DG, Lemon PW. Effect of ambient temperature on protein breakdown during prolonged exercise. J Appl Physiol. 1988 Feb;64(2):550-5.
  87. Layman DK. The role of leucine in weight loss diets and glucose homeostasis. J Nutr. 2003 Jan;133(1):261S-267S.
  88. Bassit RA, Sawada LA, Bacurau RF, Navarro F, Costa Rosa LF. The effect of BCAA supplementation upon the immune response of triathletes. Med Sci Sports Exerc. Med Sci Sports Exerc. 2000 Jul;32(7):1214-9.
  89. Bruunsgaard H, et al. In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise. Med Sci Sports Exerc. 1997 Sep;29(9):1176-81.
  90. Kaplowitz, N., T.Y. Aw & M. Ookhtens. The Regulation of Hepatic Glutathione. Ann. Rev. Pharmacol. Toxicol. 1985. 25: 715-744.
  91. Droge W, Breitkreutz R. Glutathione and immune function. Proc Nutr Soc. 2000 Nov;59(4):595-600.
  92. Robinson MK, Rodrick ML, Jacobs DO, Rounds JD, Collins KH, Saporoschetz IB, Mannick JA, Wilmore DW. Glutathione depletion in rats impairs T-cell and macrophage immune function. Arch Surg. 1993 Jan;128(1):29-34; discussion 34-5.
  93. Fidelus RK, Tsan MF. Glutathione and lymphocyte activation: a function of ageing and auto-immune disease. Immunology. 1987 Aug;61(4):503-8.
  94. Bounous G et al. 1992 Whey proteins as a food supplement in HIV-seropostive individuals. Clin.Invest. Med. Vol 16:3 p204-209.
  95. Bounous G., Batist G. & Gold P. Immunoenhancing Property of Dietary Whey Protein in Mice: Role of Glutathione. 1989. Clin. & Inv. Medicine. Vol. 12. 3: 154-161.
  96. Lands LC, Grey VL and Smountas AA. Effect of a cysteine donor on muscular performance. J Appl Physiol. 1999 Oct;87(4):1381-5.
  97. Goodman RE, Schanbacher FL. Bovine lactoferrin mRNA: sequence, analysis, and expression in the mammary gland. Biochem Biophys Res Commun. 1991 Oct 15;180(1):75-84.
  98. Markus CR, Olivier B, de Haan EH. Whey protein rich in -lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr. 2002 Jun;75(6):1051-6.
  99. Markus, CR. Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr. 2005 May; 81(5):1026-33.
  100. M., Levenez, F., Yvon, Y. and Corring, T. Effect of caseinomacropeptide (CMP) of cholecystokinin (CCK) release in rats. Reprod. Nutr. Dev. 1994. 34:613-614
  101. Yvon, M., Beucher, S., Guillteau, P., LeHuerou-Luron, I. And Corring, T. Effect of caseinomacropeptide on digestion regulation. Reprod. Nutr. Dev. 1994. 34:527-537.
  102. American Dietetic Association. 2002. Health implications of dietary fiber. J. Am. Diet. Assoc. 102: 993-1000.
  103. Pereira MA, Ludwig DS. Dietary fiber and body-weight regulation. Observations and mechanisms. Pediatr Clin North Am. 2001 Aug;48(4):969-80.
  104. Ullrich, I.H., and M.J. Albrink. 1985. The effect of dietary fiber and other factors on insulin response: role in obesity. J. Environ. Pathol. Toxicol. Oncol. 5, no. 6 (July): 137-55.
  105. Southgate, D.A. 1978. Has dietary fibre a role in the prevention and treatment of obesity. Bibl. Nutr. Dieta. 26: 70-6.
  106. Moriceau S, et al. Cholesterol-lowering effects of guar gum: changes in bile acid pools and intestinal reabsorption. Lipids. 2000 Apr;35(4):437-44.
  107. Smith, U. 1987. Dietary fibre, diabetes and obesity. Int. J. Obes. 11, Supp. 1: 27-31.
  108. Heini, A.F. 1998. Effect of hydrolyzed guar fiber on fasting and postprandial satiety and satiety hormones: a double-blind, placebo-controlled trial during controlled weight loss. Int. J. Obes. Relat. Metab. Disord. 22 (September): 906-9.
  109. Howarth, N.C., E. Saltzman, and S.B. Roberts. 2001. Dietary fiber and weight regulation. Nutr. Rev. 59 (May): 129-39.
  110. Holloway, W.D. 1983. Composition of fruit, vegetable, and cereal dietary fibre. J. Sci. Food. Agric. 34, no. 11 (November): 1236-40.
  111. McFarland GA, Holliday R. “Retardation of the senescence of cultured human diploid fibroblasts by carnosine.” Exp Cell Res. 1994 Jun; 212(2): 167-75.
  112. McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Exp Gerontol. 1999; 34(1):35-45.
  113. Hipkiss AR, Preston JE, Himswoth DT, et al. Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells. Neurosci Lett. 1997; 238(3):135-8.
  114. Hipkiss AR, Michaelis J, Syrris P. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett. 1995; 371(1):81-5.
  115. Boldyrev A, Song R, Lawrence D, et al. Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience. 1999; 94(2):571-7.
  116. Cherniske, S. The Metabolic Plan : Stay Younger Longer. Ballantine Books. New York. NY. Pg. 183, 2004
  117. Radak Z, Chung HY, Goto S. Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology. 2005;6(1):71-5.
  118. Lee S, et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes. J Appl Physiol. 2005 Apr 28.
  119. Brunet S, et al. For the patient. Exercise is important to preventing and controlling type 2 diabetes. Ethn Dis. 2005 Spring;15(2):353-4.
  120. Wei C, et al. Exercise might favor reverse cholesterol transport and lipoprotein clearance: Potential mechanism for its anti-atherosclerotic effects. Biochim Biophys Acta. 2005 Apr 5.
  121. Bacon SL, et al. Effects of exercise, diet and weight loss on high blood pressure. Sports Med. 2004;34(5):307-16.
  122. Manger TA, Motta RW. The impact of an exercise program on posttraumatic stress disorder, anxiety, and depression. Int J Emerg Ment Health. 2005 Winter;7(1):49-57.
  123. Carr DB, et al. A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function. Diabetes. 2005 Feb;54 (2):340-7.
  124. Henderson NK, White CP, Eisman JA. The roles of exercise and fall risk reduction in the prevention of osteoporosis. Endocrinol Metab Clin North Am. 1998 Jun;27(2):369-87.
  125. Jorgensen JO, et al. Exercise, hormones, and body temperature. regulation and action of GH during exercise. J Endocrinol Invest. 2003 Sep;26(9):838-42.
  126. Tanehata M, et al. Improved oxygen utilization during mild exercise in heart failure. Jpn Circ J. 1998 Oct;62(10):741-4.
  127. Waade NR. Exercise improves self-esteem in children and young people. Aust J Physiother. 2004;50(2):117.
  128. Boyer, B.T. (1990). Acomparison of the effects of three strength training programs on women. J. Applied Sport Science Research, 4, 88-94
  129. Wilmore, J.H., et al. Physiological alterations consequent to circuit weight training. Medicine and Science in Sports, (1978).10, 79-84
  130. Schwarz L, Kindermann W. Beta-endorphin, adrenocorticotropic hormone, cortisol and catecholamines during aerobic and anaerobic exercise. Eur J Appl Physiol Occup Physiol. 1990;61(3-4):165-71.
  131. McCartney, N.A., et al; “Usefulness of Weightlifting Training in Improving Strength and Maximal Power Output in Coronary Artery Disease,” Amer J Cardiol, 67 (1991):939.

Part 2 References

  1. Davis DR, Epp MD, Riordan HD. Changes in USDA food composition data for 43 garden crops, 1950 to 1999. J Am Coll Nutr. 2004 Dec;23(6):669-82.
  2. Pelletier KR. Sound Mind, Sound Body: A New Model For Lifelong Health. Fireside, New York, New York, 1994.
  3. Sapolsky, R. Why Zebras Don’t Get Ulcers, New York: W.H. Freeman and Company, 1998.
  4. King, B.J., & Schmidt, M.A.; Bio-Age: Ten Steps To A Younger You, CDG Books Canada, 2001
  5. Guay AT, Jacobson J. Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido. J Sex Marital Ther. 2002;28 Suppl 1:129-42.
  6. Lane JD, Pieper CF, Phillips-Bute BG, Bryant JE, Kuhn CM.Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosom Med. 2002 Jul-Aug;64(4):595-603.
  7. Asthma and Allergy Foundation of America, www.aafa.org
  8. Bateson-Koch, Carolee. Allergies: Disease in Disguise. Alive Books, Burnaby BC. © 1994.
  9. Kompauer I, Demmelmair H, Koletzko B, Bolte G, Linseisen J, Heinrich J. Association of fatty acids in serum phospholipids with hay fever, specific and total immunoglobulin E. Br J Nutr. 2005 Apr;93(4):529-35
  10. Gonzalez-Quintela A, Vidal C, Gude F. Alcohol, IgE and allergy. Addict Biol. 2004 Sep-Dec;9(3-4):195-204.
  11. Johnston CS. The antihistamine action of ascorbic acid. Subcell Biochem. 1996;25:189-213.
  12. Minas T, Nehrer S: Current concepts in the treatment of articular cartilage defects. Orthopedics 1997;20(6):525-538
  13. BME/ME. Cartilage Structure and Function. 456 Biomechanics. University of Michigan College of Engineering (website).
  14. Buckwalter JA, Mankin HJ: Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998;47:477-486
  15. Nelson FRT, Wagner J: An update on articular cartilage transplantation. J Musculoskel Med 1998;15(2):56-66
  16. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440.
  17. Penglis PS. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors. J Immunol. 2000 Aug 1;165(3):1605-11.
  18. Brandk KD. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med. 1987 Nov 20;83(5A):29-34.
  19. van den Berg WB. Impact of NSAID and steroids on cartilage destruction in murine antigen induced arthritis. J Rheumatol Suppl. 1991 Feb;27:122-3.
  20. Crolle G, D-Este E.Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin. 1980;7(2):104-9.
  21. Miller JS, et al. Suppression of Human Cartilage Degradation and Chondrocyte Activation by a Unique Mineral Supplement (SierraSil™) and a Cat’s Claw Extract, Vincaria® JANA. Volume 7, No. 2, 2004
  22. Smidt N, de Vet HC, Bouter LM, Dekker J; Excercise Therapy Group.Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust J Physiother. 2005;51(2):71-85.
  23. Karmisholt K, Gotzsche PC.Physical activity for secondary prevention of disease. Systematic reviews of randomised clinical trials. Dan Med Bull. 2005 May;52(2):90-4.
  24. Messier SP, Gutekunst DJ, Davis C, DeVita P.Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis Rheum. 2005 Jul;52(7):2026-32.
  25. Klein-Nulend J, Nijweide PJ, Burger EH. Osteocyte and bone structure. Curr Osteoporos Rep. 2003 Jun;1(1):5-10.
  26. MedicineNet.com, www.medicinenet.com
  27. Budak N, Cicek B, Sahin H, Tutus A.Bone mineral density and serum 25-hydroxyvitamin D level: is there any difference according to the dressing style of the female university students. Int J Food Sci Nutr. 2004 Nov;55(7):569-75.
  28. Nieves JW. Osteoporosis: the role of micronutrients. Am J Clin Nutr. 2005 May;81(5):1232S-1239S.
  29. Devine A, Dick IM, Islam AF, Dhaliwal SS, Prince RL.Protein consumption is an important predictor of lower limb bone mass in elderly women. Am J Clin Nutr. 2005 Jun;81(6):1423-8.
  30. Miggiano GA, Gagliardi L. Diet, nutrition and bone health. Clin Ter. 2005 Jan-Apr;156(1-2):47-56.
  31. Engelke, K. et al. Exercise maintains bone density at spine and hip EFOPS: a 3-year longitudinal study in early postmenopausal women. Osteoporos Int. 2005 Aug 12; [Epub ahead of print]
  32. Wickens AP. Ageing and the free radical theory. Respir Physiol. 2001 Nov 15;128(3):379-91.
  33. Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med (Maywood). 2002 Oct;227(9):671-82.
  34. Rosler M, et al. Free radicals in Alzheimer's dementia: currently available therapeutic strategies. J Neural Transm Suppl. 1998;54:211-9.
  35. The Alzheimer’s Association. US Statistics about Alzheimer’s Disease. www.alz.org
  36. Hebert, LE, et al. “Alzheimer Disease in the U.S. Population: Prevalence Estimates Using the 2000 Census.” Archives of Neurology August 2003; 60 (8): 1119 – 1122.
  37. Alzheimer Society, www.alzheimer.ca
  38. National Parkinson Foundation, www.parkinson.org
  39. Berkow, Robert et al., ed. Merck Manual of Medical Information Home Edition. New York: Pocket Books, 1997
  40. Zhu X, Smith MA, Perry G, Aliev G. Mitochondrial failures in Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2004 Nov-Dec;19(6):345-52.
  41. Kontush K, Schekatolina S.Vitamin E in neurodegenerative disorders: Alzheimer's disease. Ann N Y Acad Sci. 2004 Dec;1031:249-62.
  42. Zandi PP, et al. Cache County Study Group.Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol. 2004 Jan;61(1):82-8.
  43. Engelhart MJ, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002 Jun 26;287(24):3223-9.
  44. Boldyrev A, Koudinov A, Berezov T, Carpenter DO.Amyloid-beta induced cell death is independent of free radicals. J Alzheimers Dis. 2004 Dec;6(6):633-8; discussion 673-81.
  45. Malchair P, et al. Coenzyme Q10: biochemistry, pathophysiology of its deficiency and potential benefit of an increased intake. Rev Med Liege. 2005 Jan;60(1):45-51.
  46. Sutoo D, Akiyama K.Regulation of brain function by exercise. Neurobiol Dis. 2003 Jun;13(1):1-14.
  47. American Cancer Society. Statistics for 2005.
  48. Canadian Cancer Society www.cancer.ca
  49. Berkow, Robert et al., ed. Merck Manual of Medical Information Home Edition. New York: Pocket Books, 1997.
  50. Epstein S. The Politics of Cancer [Revisited]. East Ridge Press, 1998. USA.
  51. Dr. Otto Warburg, The Prime Cause and Prevention of Cancer, Lecture delivered to Nobel Laureates on June 30, 1966 at Lindau, Lake Constance, Germany.
  52. Burnham TR, Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc. 2002 Dec;34(12):1863-7.
  53. Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004 Oct 20;3:19.
  54. Cholst S. Cancer and stress. Med Hypotheses. 1996 Feb;46(2):101-6.
  55. News Target, www.newstarget.com
  56. National Chronic Pain Outreach Association www.chronicpain.org
  57. Narita M, et al. Chronic Pain Induces Anxiety with Concomitant Changes in Opioidergic Function in the Amygdala. Neuropsychopharmacology. 2005 Aug 10; [Epub ahead of print]
  58. Goldstein FJ. Adjuncts to opioid therapy. Am Osteopath Assoc. 2002 Sep;102(9 Suppl 3):S15-21.
  59. Gupta MA, Lanius RA, Van der Kolk BA.Psychologic trauma, posttraumatic stress disorder, and dermatology. Dermatol Clin. 2005 Oct;23(4):649-56.
  60. Brasseur L. Review of current pharmacologic treatment of pain. Drugs. 1997;53 Suppl 2:10-7.
  61. Tousignant-Laflamme Y, Rainville P, Marchand S.Establishing a link between heart rate and pain in healthy subjects: a gender effect. J Pain. 2005 Jun;6(6):341-7.
  62. Frot M, Feine JS, Bushnell MC. Sex differences in pain perception and anxiety. A psychophysical study with topical capsaicin. Pain. 2004 Apr;108(3):230-6.
  63. Soetanto AL, Chung JW, Wong TK. Gender differences in pain perception: a signal detection theory approach. Acta Anaesthesiol Taiwan. 2004 Mar;42(1):15-22.
  64. Brey RL. Both migraine and motion sickness may be due to low brain levels of serotonin. Neurology. 2005 Aug 23;65(4):E9-10.
  65. Sandor PS, Afra J. Nonpharmacologic treatment of migraine. Curr Pain Headache Rep. 2005 Jun;9(3):202-5.
  66. Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998;5(1):24-7.
  67. Bianchi A, et al. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam Horm. 2004;69:297-312
  68. Sandor PS, Afra J. Nonpharmacologic treatment of migraine. Curr Pain Headache Rep. 2005 Jun;9(3):202-5.
  69. Bryans JS. Novel treatments for pain. IDrugs. 1999 Nov;2(11):1170-82.
  70. Okada K, et al. The influence of hot pack therapy on the blood flow in masseter muscles. J Oral Rehabil. 2005 Jul;32(7):480-6.
  71. Nurmikko T, et al. Attenuation of tourniquet-induced pain in man by D-phenylalanine, a putative inhibitor of enkephalin degradation. Acupunct Electrother Res. 1987;12(3-4):185-91.
  72. Russell AL, McCarty MF. DL-phenylalanine markedly potentiates opiate analgesia - an example of nutrient/pharmaceutical up-regulation of the endogenous analgesia system. Med Hypotheses. 2000 Oct;55(4):283-8.
  73. Beckmann et al. Dl-phenylalanine in depressed patients: an open study. J Neural Transm. 1977;41(2-3):123-34.
  74. Beckmann et al. DL-phenylalanine versus imipramine: a double-blind controlled study. Arch Psychiatr Nervenkr. 1979 Jul 4;227(1):49-58.
  75. Carrero JJ, et al. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr. 2005 Jun;135(6):1393-9.
  76. Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG. 2005 Apr;112(4):466-9.
  77. Shavali S, et al. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull. 2005 Jan 30;64(6):471-9.
  78. Reer R, Ziegler M, Braumann KM. Exercise therapy as a therapeutic concept. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Aug;48(8):841-7.
  79. National Diabetes Information Clearing House, www.diabetes.niddk.nih.gov
  80. Canadian Diabetes Association, www.diabetes.ca
  81. Abuissa H, Bel DS, O'keefe JH Jr. Strategies to prevent type 2 diabetes. Curr Med Res Opin. 2005 Jul;21(7):1107-14.
  82. Lichtenstein AH, Schwab US. Relationship of dietary fat to glucose metabolism. Atherosclerosis. 2000 Jun;150(2):227-43.
  83. Mohan V, et al. Association of physical inactivity with components of metabolic syndrome and coronary artery disease-the Chennai Urban Population Study (CUPS no. 15). Diabet Med. 2005 Sep;22(9):1206-11.
  84. Gautier JF. Physical activity and type 2 diabetes. Rev Med Liege. 2005 May-Jun;60(5-6):395-401.
  85. Bruunsgaard H.Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol. 2005 Jul 20
  86. Yoo JS, Lee SJ. A Meta-Analysis of the Effects of Exercise Programs on Glucose and Lipid Metabolism and Cardiac Function in Patients with Type II Diabetes Mellitus. Taehan Kanho Hakhoe Chi. 2005 Jun;35(3):546-54.
  87. Fukuda, C. et. al., The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine 1994;121:953
  88. Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 1999 Jul;26(7):1564-9.
  89. Ernberg M, et al. Plasma and serum serotonin levels and their relationship to orofacial pain and anxiety in fibromyalgia. J Orofac Pain. 2000 Winter;14(1):37-46.
  90. Medicine Net.com www.medicinenet.com
  91. Balch, James F. and Balch, Phyllis A. Prescription for Nutritional Healing ©2000 Avery Publishing, New York.
  92. Garrison RL, Breeding PC.A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses. 2003 Aug;61(2):182-9.
  93. Kennedy G, Spence V, Underwood C, Belch JJ.Increased neutrophil apoptosis in chronic fatigue syndrome. J Clin Pathol. 2004 Aug;57(8):891-3.
  94. Segal TY, Hindmarsh PC, Viner RM. Disturbed adrenal function in adolescents with chronic fatigue syndrome. J Pediatr Endocrinol Metab. 2005 Mar;18(3):295-301.
  95. Singal A, Kaur S, Tirkey N, Chopra K. Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice. J Med Food. 2005 Spring;8(1):47-52.
  96. Juhl JH. Fibromyalgia and the serotonin pathway. Altern Med Rev. 1998 Oct;3(5):367-75
  97. Bouonous G, Molson J. Competition for glutathione precursors between the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med Hypotheses. 1999 Oct;53(4):347-9.
  98. Buonous G, et al. The influence of dietary whey protein on tissue glutathione and the diseases of aging. Clin Invest Med. 1989 Dec;12(6):343-9.
  99. Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res. 2000 Nov-Dec;20(6C):4785-92.
  100. Grey V, et al. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros. 2003 Dec;2(4):195-8. Erratum in: J Cyst Fibros. 2004 Mar;3(1):62.
  101. Middleton N, Jelen P, Bell G. Whole blood and mononuclear cell glutathione response to dietary whey protein supplementation in sedentary and trained male human subjects. Int J Food Sci Nutr. 2004 Mar;55(2):131-41.
  102. Fritz IB, Yue KTN. Long-chain carnitine acyltransferase and the role of acylcarnitine derivatives in the catalytic increase of fatty acid oxidation induced by carnitine. J Lipid Res 1963; 4:279-88.
  103. Plioplys AV, Plyoplys S. Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome. Neuropsychobiology. 1997;35(1):16-23.
  104. Forsyth LM, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999 Feb;82(2):185-91
  105. Santaella ML, Font I, Disdier OM. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome. P R Health Sci J. 2004 Jun;23(2):89-93.
  106. Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr 2001 Dec; 20(6):591-8.
  107. Lenaz G, et al. Mitochondrial bioenergetics in aging. Biochim Biophys Acta 2000 Aug 15; 1459(2-3):397-404.
  108. Zimmer G, et al. Dihydrolipoic acid activates oligomycin-sensitive thiol groups and increases ATP synthesis in mitochondria. Arch Biochem Biophys. 1991 Aug 1; 288(2):609-13.
  109. Hagen TM. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1870-5.
  110. Everhart, J. E. (Ed.). (1994). Digestive diseases in the United States: Epidemiology and impact. (NIH Publication No. 94–1447). U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: U.S. Government Printing Office.
  111. Berkow, Robert et al., ed. Merck Manual of Medical Information Home Edition. New York: Pocket Books, 1997.
  112. Digestive Diseases Statistics. http://digestive.niddk.nih.gov/statistics/statistics.htm. NIDDK
  113. Life Extension, www.lef.org
  114. May B, Kuntz HD, Kieser M, Kohler S. Arzneimforch Drug Res. 1996; 46(II) 1149-1153.
  115. Berkow, Robert et al., ed. Merck Manual of Medical Information Home Edition. New York: Pocket Books, 1997. (pp. 528-530)
  116. www.celiac.org
  117. Balch, James F., and Balch, Phyllis A. Prescription for Nutritional Healing. New York: Avery Publishing, 2000.
  118. Berkow, Robert et al., ed. Merck Manual of Medical Information Home Edition. New York: Pocket Books, 1997.
  119. Ross E. The role of marine fish oils in the treatment of ulcerative colitis. Nutr Rev. 1993 Feb;51(2):47-9.
  120. Keeble J, et al. The role of substance P in microvascular responses in murine joint inflammation. Br J Pharmacol. 2005 Apr;144(8):1059-66.
  121. Canadian Heart and Stroke Foundation, www.heartandstroke.ca
  122. American Heart Association, www. americanheart.org
  123. Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF 2nd, Peyser PA, Turner ST.C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens. 2005 Aug;18(8):1123-9.
  124. Guo H, Lee JD, Ueda T, Shan J, Wang J. Plasma homocysteine levels in patients with early coronary artery stenosis and high risk factors. Jpn Heart J. 2003 Nov; 44(6): 865-71.
  125. Miller AL, Kelly GS. Homocysteine metabolism: nutritional modulation and impact on health and disease. Altern Med Rev 1997;2:234-254.
  126. Vrentzos GE, Papadakis JA, Vardakis KE, Maliaraki N, Stilianou K, Arvanitis A, Sratigis S, Alivanis P, Margioris AN, Ganotakis ES. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease. J Nephrol. 2003 Jul-Aug; 16(4): 535-9.
  127. Gori AM, Corsi AM, Fedi S, Gazzini A, Sofi F, Bartali B, Bandinelli S, Gensini GF, Abbate R, Ferrucci L.A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr. 2005 Aug;82(2):335-41.
  128. Clarke R. Homocysteine-lowering trials for prevention of heart disease and stroke. Semin Vasc Med. 2005 May;5(2):215-22.
  129. Moat SJ, Lang D, McDowell IF, Clarke ZL, Madhavan AK, Lewis MJ, Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem. 2004 Feb;15(2):64-79.
  130. Verhoef P, de Groot LC.Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med. 2005 May;5(2):110-23.
  131. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P; PRIME Study Group.Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2005 May 10;111(18):2299-305. Epub 2005 May 2.
  132. Sandhu RS, Petroni DH, George WJ.Ambient particulate matter, C-reactive protein, and coronary artery disease. Inhal Toxicol. 2005 Jun-Jul;17(7-8):409-13.
  133. Zampelas A, Panagiotakos DB, Pitsavos C, Das UN, Chrysohoou C, Skoumas Y, Stefanadis C.Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol. 2005 Jul 5;46(1):120-4.
  134. Kasapis C, Thompson PD.The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005 May 17;45(10):1563-9. Epub 2005 Apr 25.
  135. Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M.Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol. 2005 Apr 8;100(1):93-9.
  136. Honebrink A.Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies. Expert Opin Emerg Drugs. 2005 Aug;10(3):619-41.
  137. Fishman J, Schneider J, Hershcope RJ, Bradlow HL. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem. 1984 Apr;20(4B):1077-81.
  138. Michnovicz JJ, Adlercreutz H, Bradlow HL. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst. 1997 May 21;89(10):718-23.
  139. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-hydroxyestrone: the ‘good’ estrogen. J Endocrinol. 1996 Sep;150 Suppl:S259-65
  140. McDonough PG. The randomized world is not without its imperfections: reflections on the Women's Health Initiative Study. Fertil Steril. 2002 Nov;78(5):951-6.
  141. Popat RA, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology. 2005 Aug 9;65(3):383-90.
  142. Cohen SM, Rousseau ME, Carey BL. Can acupuncture ease the symptoms of menopause? Holist Nurs Pract. 2003 Nov-Dec;17(6):295-9.
  143. Wozniak P, Oszukowski P, Stachowiak G, Szyllo K.The effectiveness of low-calorie diet or diet with acupuncture treatment in obese peri- and postmenopausal women. Ginekol Pol. 2003 Feb;74(2):102-7.
  144. Lieberman S. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Womens Health. 1998 Jun;7(5):525-9.
  145. Atkinson C. Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. J Nutr. 2004 Jul;134(7):1759-64.
  146. Johnson BE. Dietary supplements containing red clover extracts were no better than placebo for hot flashes in menopause. ACP J Club. 2004 Mar-Apr;140(2):47.
  147. Jarry H, et al. Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones. Planta Med. 2003 Oct;69(10):945-7.
  148. Rosmond, R., and P. Björntorp. “Endocrine and Metabolic Aberrations in Men with Abdominal Obesity in Relation to Anxio-depressive Infirmity.” Metabolism 47, no. 10 (October 1998):1187–1193.
  149. Rosmond, R., and P. Björntorp. “Endocrine and Metabolic Aberrations in Men with Abdominal Obesity in Relation to Anxio-depressive Infirmity.” Metabolism 47, no. 10 (1998):1187-1193.
  150. Makinen J, et al.Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol. 2005 May 17;45(10):1609-10.
  151. Wu CY, Yu TJ, Chen MJ.Age related testosterone level changes and male andropause syndrome. Chang Gung Med J. 2000 Jun;23(6):348-53.
  152. Pugeat, M., et al. “Clinical Utility of Sex Hormone-Binding Globulin Measurement.” Horm Res 45, no. 3–5 (1996):148–155.
  153. Hryb, D.J., et al. “The Effect of Extracts of the Roots of the Stinging Nettle (Urtica dioica) on the Interaction of SHBG with Its Receptor on Human Prostatic Membranes.” Planta Medica 61, no. 1 (February 1995):31–32.
  154. Schöttner, M., et al. “Lignans from the Roots of Urtica dioica and Their Metabolites Bind to Human Sex Hormone Binding Globulin (SHBG).” Planta Medica 63, no. 6 (December 1997):529–532.
  155. “BPH: The Other Side of the Coin.” Life Extension 5, no. 2 (February 1999):13–17.
  156. MacDonald, P.C. “Origin of Estrogen in Normal Men and in Women with Testicular Feminization.” Journal of Clinical Endocrinology and Metabolism 49, no. 6 (December 1979):905–916.
  157. Ravaglia G, et al. Determinants of functional status in healthy Italian nonagenarians and centenarians: a comprehensive functional assessment by the instruments of geriatric practice. J Am Geriatr Soc. 1997 Oct;45(10):1196-202.
  158. King. B. Fat Wars Action Planner. Wiley & Sons, Toronto. 2002
  159. Farnsworth WE. Estrogen in the etiopathogenesis of BPH. Prostate, 1999, 41:263-74.
  160. Campbell, D.R., and M.S. Kurzer. “Flavonoid Inhibition of Aromatase Enzyme Activity in Human Preadipocytes.” Journal of Steroid Biochemistry & Molecular Biology 46, no. 3 (September 1993):381–388.
  161. Valimaki, M.J., Harkonen, M., Eriksson, C.J., & Ylikahri, R.H.; Sex hormones and adrenocortical steroids in men acutely intoxicated with ethanol. Alcohol, 1, 89-93, 1984.
  162. American Liver Foundation, www.liverfoundation.org
  163. Schmucker DL.Age-related changes in liver structure and function: Implications for disease? Exp Gerontol. 2005 Aug 13; [Epub ahead of print]
  164. MedicineNet.com, www.medicinenet.com
  165. American Liver Foundation, www.liverfoundation.org
  166. Adams LA, Angulo P.Recent concepts in non-alcoholic fatty liver disease. Diabet Med. 2005 Sep;22(9):1129-33.
  167. Jimba S, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 2005 Sep;22(9):1141-5.
  168. Charbonneau A, Couturier K, Gauthier MS, Lavoie JM.Evidence of hepatic glucagon resistance associated with hepatic steatosis: reversal effect of training. Int J Sports Med. 2005 Jul-Aug;26(6):432-41.
  169. Asthma Society of Canada www.asthma.ca
  170. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2(1):8-11.
  171. Medicine Net.com www.medicinenet.com
  172. Brook I.Microbiology and antimicrobial management of sinusitis. J Laryngol Otol. 2005 Apr;119(4):251-8.
  173. Becker DG, Becker SS.A dedicated specialty center for nose and sinus care: an organized approach. J Long Term Eff Med Implants. 2005;15(3):273-82.
  174. Smith LJ, Holbrook JT, Wise R, Blumenthal M, Dozor AJ, Mastronarde J, Williams L; American Lung Association Asthma Clinical Research Centers. Dietary intake of soy genistein is associated with lung function in patients with asthma. J Asthma. 2004;41(8):833-43.
  175. Nagel G, Linseisen J.Dietary intake of fatty acids, antioxidants and selected food groups and asthma in adults. Eur J Clin Nutr. 2005 Jan;59(1):8-15.
  176. Spector SL, Surette ME.Diet and asthma: has the role of dietary lipids been overlooked in the management of asthma? Ann Allergy Asthma Immunol. 2003 Apr;90(4):371-7; quiz 377-8, 421.
  177. Hodge L, Salome CM, Peat JK, Haby MM, Xuan W, Woolcock AJ. Consumption of oily fish and childhood asthma risk. Med J Aust. 1996 Feb 5;164(3):137-40.
  178. Manz F, Wentz A.The importance of good hydration for the prevention of chronic diseases. Nutr Rev. 2005 Jun;63(6 Pt 2):S2-5.
  179. Lucas SR, Platts-Mills TA.Physical activity and exercise in asthma: relevance to etiology and treatment. J Allergy Clin Immunol. 2005 May;115(5):928-34.
  180. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Annals of Periodontology 1998;3:51-61
  181. Scannapieco FA, Mylotte JM. Relationships between periodontal disease and bacterial pneumonia. J Periodontal 1996;67:1114-1122
  182. Scannapieco, FA, Papandonatos GD, Dunford RG, Association between oral conditions and respiratory disease in a national sample survey population. Annals of Periodontology 1998;3:257-261
  183. Berkow, Robert et al., ed. Merck Manual of Medical Information Home Edition. New York: Pocket Books, 1997.
  184. Fluroide Action Network, www.fluoridealert.org
  185. Enwonwu CO, Sanders C. Nutrition: impact on oral and systemic health. Compend Contin Educ Dent. 2001 Jul;22(3 Spec No):12-8.
  186. Nakamura R, et al. Study of CoQ10-enzymes in gingiva from patients with periodontal disease and evidence for a deficiency of coenzyme Q10. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1456-60.
  187. Horiba N, et al. A pilot study of Japanese green tea as a medicament: antibacterial and bactericidal effects. J Endod. 1991 Mar;17(3):122-4.
  188. American Heart Association, Heart Disease and Stroke Statistics—2005 Update www.americanheart.org
  189. Wyne KL. Metabolic syndrome: demographic features, etiology, and clinical management. Curr Atheroscler Rep. 2005 Sep;7(5):381-8.
  190. Shaw DI, Hall WL, Williams CM. Metabolic syndrome: what is it and what are the implications? Proc Nutr Soc. 2005 Jul;64(3):349-357.
  191. Cohn GS, Kittleson MM, Blumenthal RS.Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance. Am J Hypertens. 2005 Aug;18(8):1099-103
  192. National Cholesterol Education Program, Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), National Heart, Lung, and Blood Institute, National Institutes of Health, May 2001.
  193. As We See It. What You Don’t Know About Blood Sugar. Life Extension Magazine. Jan. 2004.
  194. Harrison’s Principles of Internal Medicine, Thirteenth Edition, McGraw-Hill, 1994.p. 2001 “In one study in normal persons (arterialized venous samples), insulin secretion ceased at a 4.6 nmol/L glucose (83mg/dl).
  195. As We See It. What You Don’t Know About Blood Sugar. Life Extension Magazine. Jan. 2004.
  196. National Diabetes Information Clearing House, www.diabetes.niddk.nih.gov/dm/pubs/preventionprogram
  197. Shaw DI, Hall WL, Williams CM. Metabolic syndrome: what is it and what are the implications? Proc Nutr Soc. 2005 Jul;64(3):349-357.
  198. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association. 2002;288:1723-1727.
  199. U.S. Department of Health and Human Services. The Surgeon General’s Call to Action to Prevent and Decrease Overweight and Obesity, 2001.
  200. Healthy today, healthy tomorrow? Findings from the National Population Health Survey. [Obesity: a growing issue]. Statistics Canada, April 7, 2005.
  201. Sturm, R., and K.B. Wells. “Does Obesity Contribute as Much to Morbidity as Poverty or Smoking?” Public Health 115 (2001): 229-295.
  202. St Jeor ST, et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group II: age-dependent risk factors for obesity and comorbidities. Circulation. 2004 Nov 2;110(18):e471-5.
  203. Gidding SS, et al. Severe obesity associated with cardiovascular deconditioning, high prevalence of cardiovascular risk factors, diabetes mellitus/hyperinsulinemia, and respiratory compromise. J Pediatr. 2004 Jun;144(6):766-9.
  204. Calderon KS, Yucha CB, Schaffer SD. Obesity-related cardiovascular risk factors: intervention recommendations to decrease adolescent obesity. J Pediatr Nurs. 2005 Feb;20(1):3-14.
  205. Powell A, et al. Obesity: a preventable risk factor for large joint osteoarthritis which may act through biomechanical factors. Br J Sports Med. 2005 Jan;39(1):4-5.
  206. NHANES III. National Center for Health Statistics. Health, United States. 1995. Hyattsville, MD, Public Health Service, 1996.
  207. National Kidney and Urologic Disease Information Clearance, www.kidney.niddk.nih.gov
  208. Rebbeck TR. Genetics, disparities, and prostate cancer. LDI Issue Brief. 2005 May-Jun;10(7):1-4.
  209. Moreno J, Krishnan AV, Feldman D. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer. J Steroid Biochem Mol Biol. 2005 Jul 14; Epub ahead of print
  210. Barnard RJ, Aronson WJ. Preclinical models relevant to diet, exercise, and cancer risk. Recent Results Cancer Res. 2005;166:47-61.
  211. Walker M, et al. Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer. 2005 Sep 10;116(4):592-8.
  212. Bidoli E, et al..Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol. 2005 Jan;16(1):152-7.
  213. Hughes-Fulford M, et al. Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. Carcinogenesis. 2005 Sep;26(9):1520-6.
  214. Stacewicz-Sapuntzakis M, Bowen PE. Role of lycopene and tomato products in prostate health. Biochim Biophys Acta. 2005 May 30;1740(2):202-5. Epub 2005 Mar 13.
  215. Vij U, Kumar A. Phyto-oestrogens and prostatic growth. Natl Med J India. 2004 Jan-Feb;17(1):22-6.
  216. Habib FK, et al.Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Int J Cancer. 2005 Mar 20;114(2):190-4.
  217. John EM, et al. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 2005 Jun 15;65(12):5470-9.
  218. Barnard RJ, Aronson WJ. Preclinical models relevant to diet, exercise, and cancer risk. Recent Results Cancer Res. 2005;166:47-61.
  219. Jian L, Shen ZJ, Lee AH, Binns CW.Moderate physical activity and prostate cancer risk: a case-control study in China. Eur J Epidemiol. 2005;20(2):155-60.
  220. Marieb, E.N. Essentials of Human Anatomy and Physiology. 6th ed. San Francisco: Addison Wesley Longman Inc., 2000.
  221. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. “Acne vulgaris: a disease of Western civilization.” Arch Dermatol. (2002): Dec;138(12):1584-90.
  222. Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD. High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2005 Feb;52(2):207-14.
  223. Chiu A, Chon SY, Kimball AB. “The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress.” Arch Dermatol. (2003): Jul; 139(7): 897-900.
  224. Isolauri E, Arvola T, Sutas Y, et al. “Probiotics in the management of atopic eczema.” Clin Exp Allergy (2000):30:1605-1610.
  225. Horrobin DF. Essential fatty acid metabolism and its modification in atopic eczema. Am J Clin Nutr. 2000 Jan;71(1 Suppl):367S-72S
  226. Yasumoto R, Fujita H, Yamamoto T. “The effectiveness, safety and usefulness of borage oil on atopic dermatitis.” Acta Dermatologica (1996):92(2):249-251.
  227. Maurice F, et al. “The effects of dietary supplementation with fish oil in patients with psoriasis.” Br J Dermatol. (1987):1117:599-606.
  228. Maas, JB. Power Sleep. 1998. Villard Books. New York, NY.
  229. National Sleep Foundation. Drowsy Driving Fact Sheet. Oct. 24, 1995. Washington, D.C.
  230. Dement WC. [Forward] 101 Questions About Sleep and Dreams. Wakefulness-Sleep Education and Research Foundation. 1993. Del Mar, California.
  231. Vorona, RD, et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med. 2005 Jan 10; 165(1):25-30.
  232. Shahrad, Taheri, et al. Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index. 2004 Dec. Volume 1, Issue 3
  233. Spiegel, K, et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004 Dec 7; 141(11):846-50.
  234. Vgontzas, AN, et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999 Aug; 84(8):2603-7.
  235. Van Dongen, HP, et al. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003 Mar 15; 26(2):117-26.
  236. Lack of Sleep May Lead to Excess Weight. Press release. North American Association for the Study of Obesity. November 16, 2004. Las Vegas, NV
  237. Spiegel, K, Leproult, R, Van Cauter, E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999 Oct 23; 354(9188):1435-9.
  238. Ohayon, MM. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med. 2005 Jan 10; 165(1):35-41.
  239. Fredriksen, K, et al. Sleepless in Chicago: tracking the effects of adolescent sleep loss during the middle school years. Child Dev. 2004 Jan-Feb; 75(1):84-95.
  240. Owens, JA, et al. Sleep habits and sleep disturbance in elementary school-aged children. J Dev Behav Pediatr. 2000 Feb; 21(1):27-36.
  241. King, B. Fat Wars Action Planner. Wiley & Sons. Toronto, Ont. 2003.
  242. Maurizi, CP. The therapeutic potential for tryptophan and melatonin. Med. Hypoth 1990; 31:233-42.
  243. Moskowitz, DS, et al. The effect of tryptophan on social interaction in everyday life: a placebo-controlled study. Neuropsychopharmacology. 2001 Aug; 25(2):277-89.
  244. Soloff, PH, et al. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Alcohol Clin Exp Res. 2000 Nov; 24(11):1609-19.
  245. Markus, CR. Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr. 2005 May; 81(5):1026-33.
  246. Stuck LM, McFarland KF. Hypothyroidism in the elderly. When symptoms are not a 'normal' part of aging. Postgrad Med. 1991 Dec;90(8):141-3, 146.
  247. Broda B. Hypothyroidism: The Unsuspected Illness. Harper Collins. New York, NY. 1976
  248. Dayan CM, Saravanan P, Bayly G. Whose normal thyroid function is better—yours or mine? Commentary The Lancet 2002 Aug 03; 360 (9330): 353.
  249. Bemben DA et al. Thyroid disease in the elderly. Part 1. Prevalence of undiagnosed hypothyroidism. J Fam Pract. 1994 Jun;38(6):577-82.
  250. Bemben DA et al. Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism. J Fam Pract. 1994 Jun;38(6):583-8.
  251. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998 Sep;8(9):803-13.
 
 

This web site is for informational purposes only. Consult your health care practitioner for any medical advice. The statements made on this web site or any of its publications have not been evaluated by the Food and Drug Administration or Health Canada. This web site is not intended to diagnose, treat, cure or prevent disease.

© 2008 Transforming Health Inc.